Gelpi, E
Epithalon is not appropriate for everyone, and candidacy depends on your history, current health, and goals
This guide explains what BPC-157 is, who it may help, how it works, the benefits and the real limits of the evidence, how it is delivered, and what treatment involves
While uncomfortable, its usually short-lived and completely manageable with hydration, dietary balance, and guidance from your GP
Adolescents aged 14-20 with alcohol use disorder and mild depressive symptoms can join this trial
Safety profile: high Mechanism: incomplete Optimal SC dose: unvalidated If you choose to use it, do so consciously: Start at the minimum effective dose, track your outcomes, and adjust your protocol based on YOUR physiology